Revenue

Why Encounters Matter

Encounter data really didn’t matter much 5 – 10 years ago…so what has changed? Health plans typically viewed encounter data as just another output from the claims payment process; that’s…

Read Full Article

Trump’s Blueprint on International Drug Pricing; What to Expect

The U.S. always stood out as a different healthcare system. Well, maybe not anymore. The Trump Administration released an International Drug Pricing blueprint in 2018 and it was received with…

Read Full Article

Discount Safe Harbor Proposed Rule: How Process Works and What does it mean?

July 2019 Update As first reported by The Wall Street Journal and Axios on July 11, 2019, the Trump Administration has decided to abandon implementation of the proposed Discount Safe…

Read Full Article

The ASP challenge in Life Sciences

For most companies who perform worldwide transactions, there is a certain challenge to creating ASP transparency. In an ideal world, all the transactions are properly consolidated and budgeting your price…

Read Full Article